Heron Therapeutics | HRTX - Interest Income


Heron Therapeutics reported $433K in Interest Income for its fiscal quarter ending in December of 2021.





Interest Income Change Date
ALKERMES USD 8.54M 3.59M Mar/2026
Alnylam Pharmaceuticals USD 26.6M 32K Mar/2026
Amarin USD 3.37M 3.37M Dec/2024
Arrowhead Research USD 16.93M 66K Jun/2026
Eisai JPY 3.11B 783M Mar/2024
GlaxoSmithKline GBP 22M 96M Mar/2026
Heron Therapeutics USD 433K 277K Dec/2021
Insmed USD 765K 55K Sep/2024
Ligand Pharmaceuticals USD 6.65M 262K Mar/2026
Merck USD 35M 34M Mar/2026
Nektar Therapeutics USD -0.18 0.07 Sep/2024
Pacira USD 1.93M 365K Mar/2026
Regeneron Pharmaceuticals USD 183.3M 200K Jun/2026
Ultragenyx Pharmaceutical USD 6M 512K Mar/2026
Veracyte USD 3.48M 4K Mar/2026
Vertex Pharmaceuticals USD 120.6M 5.8M Jun/2026